| NCT02710266 | Liver Disease | Drug: Preoperative Gabexate Mesilate group|Drug: Intraoperative Gabexate Mesilate group|Drug: hepatectomy with dextrose water | Yonsei University | Phase 3 | 2016-02-01 | 2016-11-14 |
| NCT01910714 | HIV/AIDS | Behavioral: Focus On Youth|Behavioral: Health Education Control Condition | Johns Hopkins Bloomberg School of Public Health | | 2010-09-01 | 2015-04-15 |
| NCT01528761 | Physical Activity | Behavioral: Prosocial Behavior Physical Activity (PBPA)|Other: Healthy Aging (HA) | Wake Forest University Health Sciences | | 2012-02-01 | 2016-01-21 |
| NCT00887055 | Heart Failure | Device: CRT device | Guidant Corporation | Phase 4 | null | 2015-06-26 |
| NCT00747019 | Health-Related Quality of Life|Physical Activity|Physical Function | Behavioral: Prosocial Behavior Physical Activity (PBPA)|Behavioral: Physical Exercise (PE) | National Institute on Aging (NIA) | | 2008-12-01 | 2009-06-30 |
| NCT01716130 | Patient Response to Fluzone ID Vaccine | | Touro University, California|Sanofi | | 2011-10-01 | 2012-10-24 |
| NCT03075813 | Infection Control|Surgical Site Infection | Other: Intervention Cluster | Duke University|Agency for Healthcare Research and Quality (AHRQ) | | 2017-03-01 | 2017-03-16 |
| NCT02501577 | Intubation; Difficult | Device: SAD 1|Device: SAD 2 | University of Regensburg | | 2015-03-01 | 2015-07-16 |
| NCT02782156 | Substance Withdrawal Syndrome | Other: Process evaluation | University Hospital, Basel, Switzerland | | 2014-11-01 | 2016-07-11 |
| NCT02693093 | Chronic Pancreatitis | Drug: NI-03|Drug: Placebo | Stason Pharmaceuticals, Inc. | Phase 1|Phase 2 | 2015-12-01 | 2016-07-22 |
| NCT01002911 | Arrythmias | Drug: Cefazolin, Bacitracin, Cefalexin|Drug: Cefazolin | Population Health Research Institute | Phase 3 | 2009-12-01 | 2013-05-14 |
| NCT00835445 | Nasal Polyps|Asthma | | Laval University | | 2007-07-01 | 2011-01-06 |
| NCT01380496 | To Determine Bioequivalence Under Fed Conditions. | Drug: doxycycline monohydrate|Drug: doxycycline monohydrate|Drug: doxycycline monohydrate | Par Pharmaceutical, Inc.|Anapharm | Phase 1 | 1999-11-01 | 2011-06-22 |
| NCT01380483 | To Determine Bioequivalence Under Fasting Conditions | Drug: doxycycline monohydrate|Drug: doxycycline monohydrate | Par Pharmaceutical, Inc.|Anapharm | Phase 1 | 2000-01-01 | 2011-06-22 |
| NCT01282814 | Healthy | Drug: Venlafaxine Hydrochloride|Drug: Effexor庐 XR | Teva Pharmaceuticals USA | Phase 1 | 2003-02-01 | 2011-02-11 |
| NCT01282801 | Healthy | Drug: Venlafaxine Hydrochloride|Drug: Effexor庐 XR | Teva Pharmaceuticals USA | Phase 1 | 2002-09-01 | 2011-02-11 |
| NCT01260896 | Healthy | Drug: Venlafaxine Hydrochloride|Drug: Effexor庐 XR | Teva Pharmaceuticals USA | Phase 1 | 2002-09-01 | 2011-01-24 |
| NCT01190761 | Healthy | Drug: Galantamine 4 mg Tablet, single dose|Drug: Reminyl 4 mg Tablet, single dose | Actavis Inc. | Phase 1 | 2004-12-01 | 2010-08-27 |
| NCT01190748 | Healthy | Drug: Galantamine 4 mg Tablet, single dose|Drug: Reminyl 4 mg Tablet, single dose | Actavis Inc. | Phase 1 | 2004-11-01 | 2010-08-27 |
| NCT01149460 | Healthy | Drug: Valacyclovir|Drug: Valacyclovir | Teva Pharmaceuticals USA | Phase 1 | 2004-09-01 | 2010-08-18 |
| NCT01124175 | Healthy | Drug: Losartan|Drug: Cozaar庐 | Teva Pharmaceuticals USA | Phase 1 | 2003-10-01 | 2010-11-22 |
| NCT01053689 | Healthy | Drug: Glimepiride tablets 1 mg | Dr. Reddy's Laboratories Limited | Phase 1 | 2003-12-01 | 2010-01-19 |
| NCT01052909 | Healthy | Drug: Glimepiride | Dr. Reddy's Laboratories Limited | Phase 1 | 2003-12-01 | 2010-01-19 |
| NCT01044706 | Healthy | Drug: Bicalutamide | Kremers Urban Development Company|Watson Pharmaceuticals | Phase 1 | 2005-05-01 | 2010-02-28 |
| NCT00973050 | Healthy | Drug: Bicalutamide|Drug: Casodex庐 | Teva Pharmaceuticals USA | Phase 1 | 2003-09-01 | 2009-09-08 |
